Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese.

Furthermore, there were also numerically a higher proportion of IVIg-treated patients with autoimmune/autoinflammatory disorders (which require higher dosing of immunoglobulin) and SCIg patients had longer duration of overall immunoglobulin replacement (which may have led to better tailoring of dosing regimen), although both variables did not reach statistical significance.

also in 111,027 other papers